Matt, Author at European Medical Journal - Page 116 of 212

Repair of Distal Hypospadias: Cosmetic or Reconstructive?

Hypospadias is one of the most common congenital anomalies of male genitalia and is usually repaired in the first 2 years of life. This article reviews the authors’ experience in boys who presented with symptoms secondary to untreated distal hypospadias.

EAU 2019 - Opening Ceremony

Our full congress review of EAU 2019 will be available soon for free in our Urology 7.1 eJournal, but here is a look at the opening ceremony while you wait..

EAU 2019 - Interview - Prof Hendrik Van Poppel

An interview with Prof Hendrik Van Poppel, Chairman of the Scientific Committee of Europa Uomo, Board Member of European Cancer Organisation on…

New Insights into Gestational Diabetes Management

A TEAM of researchers from Cardiff University, Cardiff, UK have found that mothers receiving insulin and/or metformin treatment during gestational..

Diabetes Treatment Could Play a Role in Protecting Against Alzheimer’s Disease

ALZHEIMER’S DISEASE could have a higher prevalence in patients who have untreated diabetes. Researchers from the University of Southern California..

Skin Could Play a Major Role in Chronic Diseases

KEEPING skin moisturised and in good condition could decrease the risk of several chronic conditions such as heart disease, Alzheimer’s, and diabetes..

Fungi Species Key in Development of Atopic Dermatitis

YEAST species responsible for protection against fungi on the skin is also pivotal in the development of atopic dermatitis symptoms..

Importance of screening for early-onset colorectal cancer

RESEARCH into early-onset colorectal cancer (CRC) has found unique subgroups among younger patients and has outlined risk factors and prevalence of…

Obesity-targeting procedures can lower cancer risk in women

Obesity is a known risk factor for a multitude of cancers, including pancreatic, ovarian, and liver, and contributes to an estimated 15–20% of all cancer…

New Insights into Prostate Cancer Treatment

ANDROGEN deprivation therapy (ADT) is commonly used for the treatment of metastatic hormone sensitive prostate cancer (mHSPC)…